Patient Characteristics and Clinical Outcomes with Low-Dose Dabigatran

Patient Characteristics and Clinical Outcomes with Low-Dose Dabigatran

Background/aimsDabigatran, an oral direct thrombin inhibitor, is used in patients with non-valvular atrial fibrillation to reduce thromboembolic events. Whereas the 150 mg dosing regimen has been extensively studied in clinical setting, to date, there is no clinical data on the 75 mg (low dose, “LD”...

Full description

Bibliographic Details
Main Authors: Ramin Ebrahimi, Janet K. Han, Seung H. Goe, Michelle Treadwell, Zenaida Feliciano
Format: Article
Language:English
Published: Frontiers Media S.A. 2017-07-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
low-dose dabigatran
atrial fibrillation
dabigatran 75 mg
oral anticoagulant
patient demographics
Online Access:http://journal.frontiersin.org/article/10.3389/fcvm.2017.00042/full

Similar Items

Similar Items